Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06644222

Effectiveness of Airrosti and TheraBand Exercises on Double-Crossed Syndrome in Smart Phone User's Shoulder

The Effectiveness of Airrosti and TheraBand Exercises on Pain and Disability on Double-Crossed Syndrome in Smart Phone User's Shoulder

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Majmaah University · Academic / Other
Sex
Female
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

Double-crossed syndrome" refers to a specific alignment of overactive and underactive muscles in the neck, chest, and shoulders. AIRROSTI stands for Applied Integration for the Rapid Recovery of Soft Tissue Injuries. This study aims to evaluate the effectiveness of Airrosti exercises combined with TheraBand exercises in reducing pain and disability in the neck and shoulders. TheraBand exercise programs are commonly used to improve muscle activation. However, research on the effectiveness of AIRROSTI combined with TheraBand exercises for treating Double-Crossed Syndrome among smartphone users is limited, and more evidence is needed to support their effectiveness.

Detailed description

Research objective is to evaluate the effectiveness of Airrosti and Theraband exercises in reducing pain and disability among smartphone users with Double-Crossed Syndrome. To evaluate the combined effect of Airrosti and Theraband exercises in reducing pain and disability among smartphone users with Double-Crossed Syndrome. To compare the effect of Airrosti and Theraband exercises in reducing pain and disability among smartphone users with Double-Crossed Syndrome.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAIRROSTI exercisesGroup A will receive AIRROSTI exercises for 45 minutes / one session daily for five days per week
BEHAVIORALThera band exercisesGroup B will receive Thera band exercises for 45 minutes/one session per day for five days per week.

Timeline

Start date
2024-12-10
Primary completion
2025-12-15
Completion
2025-12-30
First posted
2024-10-16
Last updated
2025-05-20

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT06644222. Inclusion in this directory is not an endorsement.